Search

Search Results
Results 37841 - 37850 of 37911 for Tumors
  • Somavert
    Drug - 31 Jan 2023
    Consumer Medicine Information (CMI) about Somavert intended for persons living in Australia.
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Genotropin
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Genotropin intended for persons living in Australia.
  • Genotropin MiniQuick
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Genotropin MiniQuick intended for persons living in Australia.
  • Minitran
    Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Minitran intended for persons living in Australia.
  • Busulfex
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Busulfex intended for persons living in Australia.
  • Ovaleap
    Drug - 23 May 2022
    Consumer Medicine Information (CMI) about Ovaleap intended for persons living in Australia.
  • Screening memory T cell frequency using an optimized, multiplex flow cytometry assay
    White Paper - 28 Apr 2022
    In this article, Sartorius demonstrates how their iQue® can be used to reliably and accurately screen for memory T cell frequency through an optimized, multiplex flow cytometry assay.
  • Aurorix
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Aurorix intended for persons living in Australia.
  • Amira 150 and Amira 300
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Amira 150 and Amira 300 intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback